LIXTE BIOTECHNOLOGY HLDGS IN's ticker is LIXT and the CUSIP is 539319202. A total of 16 filers reported holding LIXTE BIOTECHNOLOGY HLDGS IN in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 99,644 | $56,000 | 0.07% |
| SANTA MONICA PARTNERS LP | 166,667 | $93,000 | 0.07% |
| Virtu Financial LLC | 12,784 | $7,000 | 0.00% |
| Warberg Asset Management LLC | 14,500 | $8,000 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 21,274 | $12,000 | 0.00% |
| FMR LLC | 100 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 51 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 25,794 | $14,000 | 0.00% |
| STATE STREET CORP | 35,956 | $20,000 | 0.00% |